S. 832 · 119th Congress

EPIC Act of 2025

Introduced on Mar 4, 2025 by Thom Tillis (R-NC). 7 cosponsors, all from the sponsor's party. Latest action (Mar 4, 2025): Read twice and referred to the Committee on Finance.

Stage
Introduced
Introduced
Mar 4, 2025
Cosponsors
7
0 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Thom TillisR-NCSponsor

Republicans · 7

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Mar 4, 2025Introduced in Senate
  2. Mar 4, 2025 · SenateRead twice and referred to the Committee on Finance.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA27 reports
    $57.5M reported (all issues)
  2. NOVARTIS CORPORATION15 reports
    $13.1M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  3. Pharmaceutical Research and Manufacturers of America (PhRMA)8 reports
    $290K reported (all issues)
  4. SOLENO THERAPEUTICS, INC.7 reports
    $370K reported (all issues)
  5. BIOGEN INC.6 reports
    $5.7M reported (all issues)
  6. BOEHRINGER INGELHEIM USA CORPORATION6 reports
    $5.5M reported (all issues)Federal contractor: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC$3.5M in contracts, FY2026AI match · 99%
  7. Bayer Corporation (consolidated report)6 reports
    $13.1M reported (all issues)
  8. EMD SERONO, INC.6 reports
    $4.7M reported (all issues)
  9. GSK (fka GLAXOSMITHKLINE INC.)6 reports
    $7.4M reported (all issues)
  10. HealthCare Institute of New Jersey6 reports
    $283.8K reported (all issues)
  11. JOHNSON & JOHNSON SERVICES, INC.6 reports
    $13.3M reported (all issues)
  12. Job Creators Network6 reports
    $36.8K reported (all issues)
  13. LUNDBECK LLC6 reports
    $930K reported (all issues)Federal contractor: LUNDBECK LLCAI match · 99%
  14. NEUROCRINE BIOSCIENCES, INC.6 reports
    $5.5M reported (all issues)Federal contractor: NEUROCRINE BIOSCIENCES, INC.AI match · 100%
  15. Public Citizen6 reports
    $548.1K reported (all issues)
  16. TAKEDA PHARMACEUTICALS AMERICA, INC.6 reports
    $6M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  17. ACADIA PHARMACEUTICALS5 reports
    $3.1M reported (all issues)
  18. HARMONY BIOSCIENCES, LLC5 reports
    $870K reported (all issues)Federal contractor: HARMONY BIOSCIENCES LLC$614.4K in contracts, FY2026AI match · 100%
  19. PFIZER INC.5 reports
    $10.8M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  20. OTSUKA AMERICA PHARMACEUTICAL, INC4 reports
    $3.7M reported (all issues)Federal contractor: OTSUKA AMERICA PHARMACEUTICAL INCAI match · 100%
  21. Personalized Medicine Coalition4 reports
    $170K reported (all issues)
  22. SANOFI US SERVICES INC4 reports
    $7.1M reported (all issues)
  23. AARP3 reports
    $14.2M reported (all issues)
  24. BIOTECHNOLOGY INNOVATION ORGANIZATION3 reports
    $5.5M reported (all issues)
  25. IONIS PHARMACEUTICALS, INC.3 reports
    $370K reported (all issues)
  26. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION3 reports
    $10.5M reported (all issues)
  27. Families USA Foundation, Inc.2 reports
    $37K reported (all issues)
  28. GILEAD SCIENCES, INC.1 report
    Federal contractor: GILEAD SCIENCES INCAI match · 100%
  29. Healthcare Leadership Council1 report
    $200K reported (all issues)
  30. PRIME THERAPEUTICS LLC1 report
    $100K reported (all issues)
  31. THE ALS ASSOCIATION1 report
    $30K reported (all issues)

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 7, 2026 · loaded Oct 7, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 7, 2026 · loaded Oct 7, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.